Maxwell Healthcare Associates (MHA) has entered a collaboration with Hospice Dynamix and Medalogix to transform hospice care delivery.
With comprehensive industry knowledge, MHA plans to help home health and hospice agencies navigate the evolving healthcare landscape by offering varied services.
Go deeper with GlobalData
Hospice Dynamix focuses on hospice Predictive Length of Stay (LOS) analytics, utilising AI, machine learning, and natural language processing to improve care and operational efficiency.
It is claimed to be the first decision intelligence software that can predict the length of stay for hospice patients.
This software provides a dynamic and continuous LOS prediction from admission through the service period.
The user-friendly dashboard offers Medicare revenue projections, cap calculations, census management tools, compliance threat identification, and referral source benchmarking based on PLOS metrics.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataMaxwell Healthcare Associates co-founder and CEO Jennifer Maxwell saif: “We are thrilled to embark on this tripartite partnership with Hospice Dynamix and Medalogix.
“By combining our industry expertise with the innovative solutions offered by our partners, we are poised to make significant strides in enhancing hospice care delivery and setting new industry standards.”
Medalogix will offer its Muse platform to the partnership.
A resource management tool, Muse informs optimal care timing for hospice patients.
It has been instrumental in helping hospice providers anticipate patient needs and allocate resources effectively.
Currently, 20% of all Medicare Hospice patients are managed using Muse.
MHA, Hospice Dynamix and Medalogix will merge their expertise to transform the hospice care landscape and deliver improved outcomes for patients and their families.
Medalogix CEO Elliott Wood said: “Hospice Dynamix has a very innovative approach to providing insight into issues regarding financial and compliance liability for our hospice customers.
“Medalogix has historically focused on clinical delivery and operational excellence. The collaboration between these two companies offers an opportunity for our customers to excel in all the above.”
